CERENIS THERAPEUTICS Quotes Cerenis Therapeutics LIQUIDNET SYSTEMS
Equities
FR0012616852
Biotechnology & Medical Research
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.187 EUR | 0.00% |
|
0.00% | 0.00% |
| 03-14 | Abionyx Pharma: to benefit from a 1ME grant from Bpifrance | CF |
| 03-11 | Abionyx: reduced net loss in 2023 | CF |
Volumes
marketsCapital turnover ratio
0.00
Float rotation
0.00
Basic data
Capitalization (EUR)
39 267 629
Capitalization (USD)
42 257 859
Net sales (EUR)
4 600 000
Net sales (USD)
4 950 290
Free-Float
68.01 %
Free-Float capitalization (EUR)
26 917 600
Free-Float capitalization (USD)
28 967 375
Indicators
RSI 9 days
0.00
RSI 14 days
0.00
Sector Comparison - Bio Therapeutic Drugs
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| 0.00% | 0.00% | - | - | 42.26M | ||
| +0.05% | +2.79% | +18.77% | +41.89% | 125B | ||
| -0.12% | +1.24% | +14.05% | +32.85% | 108B | ||
| -2.35% | -4.75% | -7.16% | -10.76% | 24.21B | ||
| -1.13% | +2.91% | +2.07% | -3.81% | 22.78B | ||
| -0.39% | -0.75% | -10.79% | -28.16% | 17.96B | ||
| -0.45% | +0.66% | -41.74% | -37.14% | 16.43B | ||
| -0.19% | +6.72% | -13.47% | -26.80% | 16.37B | ||
| -0.20% | -3.73% | +2.23% | +44.08% | 13.58B | ||
| -0.59% | -1.32% | +27.13% | -5.75% | 11.66B | ||
| +5.36% | +7.08% | +93.29% | +207.18% | 9.17B | ||
| -0.07% | +13.76% | -24.31% | -33.31% | 8.31B | ||
| -4.15% | -2.83% | +4.39% | +41.00% | 7.87B | ||
| +1.28% | -0.50% | +14.46% | +38.52% | 7.72B | ||
| +0.62% | -0.89% | -5.02% | +23.07% | 7.29B | ||
| +0.61% | +13.56% | +38.42% | +51.90% | 6.47B | ||
| Average | -0.02% | +3.02% | +7.49% | +22.32% | ||
| Weighted average by Cap. | +0.08% | +3.41% | +9.91% | +25.21% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
- Stock Market
- Equities
- ABNX Stock
- Stock
- Quotes Cerenis Therapeutics
